continu pipelin progress
follow product lower tp
bottom line updat glpg model follow compani
earn releas glpg report ep vs cs
estim revenu cs estim
updat model lead ep move
mainli driven
significantli increas expens account invest glpg
make behind pipelin dcf-deriv target price come
maintain neutral rate upsid risk includ
stronger-than-expect data cystic fibrosi cf triplet summer
filgotinib addit indic studi
potenti acquir downsid risk includ pipelin setback
notabl filgotinib cf franchis
compani
investor focu shift beyond filgotinib
cf vast major valuat glpg come filgotinib
cf compani make posit stride pipelin asset ipf
osteoarthr atop dermat give littl credit asset
given limit data seen encourag
stori get diversifi given challeng see
keep cf space filgotinib
encourag hear partner recent comment around
progress make clinic program may abl
file rheumatoid arthriti indic least next year glpg
initi two phase studi glpg ipf phase
studi glpg osteoarthr phase studi
atop dermat convers compani
learn initi phase studi throughout cours
year contribut high oper cash burn guidanc
valuat metric
number share
price month
amsterdam exchang
close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
us thousand unless otherwis state
euro except per share amount
 revenu
sale
research develop expenditur
restructur integr cost
net profit/ loss continu oper
net incom discontinu oper
galapago clinic stage biotech compani focus
develop novel treatment rheumatoid arthriti inflammatori
bowel diseas cystic fibrosi idiopath pulmonari fibrosi
price rate neutral target price analyst vamil divan
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
cash-flow financ activ
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
blue sky valuat base po filgotinib
increas peak probabl adjust end user sale
cf franchis blue sky valuat base dcf
driven wacc discount cash flow
termin growth rate thereaft
grey sky valuat base po filgotinib
po cf franchis grey sky valuat base
dcf driven wacc discount cash flow
termin growth rate thereaft
amsterdam exchang close
compani mention price
